ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $562,000 | +2.7% | 385,013 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $547,000 | -18.8% | 385,013 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $674,000 | +7.7% | 385,013 | +5.2% | 0.00% | 0.0% |
| Q2 2016 | $626,000 | -9.4% | 366,145 | +4.4% | 0.00% | 0.0% |
| Q1 2016 | $691,000 | +3.6% | 350,838 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $667,000 | -0.4% | 350,838 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $670,000 | -58.8% | 350,838 | 0.0% | 0.00% | -66.7% |
| Q2 2015 | $1,628,000 | -59.5% | 350,838 | -61.9% | 0.00% | -62.5% |
| Q1 2015 | $4,024,000 | +29.4% | 920,737 | +2.8% | 0.01% | +33.3% |
| Q4 2014 | $3,109,000 | -17.2% | 895,968 | -0.1% | 0.01% | -25.0% |
| Q3 2014 | $3,757,000 | -28.5% | 896,748 | 0.0% | 0.01% | -27.3% |
| Q2 2014 | $5,255,000 | -7.9% | 896,748 | -1.0% | 0.01% | -8.3% |
| Q1 2014 | $5,707,000 | +8.4% | 905,898 | +0.7% | 0.01% | 0.0% |
| Q4 2013 | $5,265,000 | – | 899,988 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |